DFC

                                                                            Main navigation

      
      Who We Are
                            About Us
                      Overview
                      Careers
                            Hiring Paths
                      Career Paths
                      Events
                      DEIA
                      Contact
                      Our People
                            Executive Staff
                      Board of Directors
                      Development Advisory Council
                      What We Do
                            Our Work
                            Regions
                      Sectors
                      Initiatives
                      Active Projects
                      Investment Stories
                      What We Offer
                            Our Products
                            Debt Financing
                      Equity Investments
                      Investment Funds
                      Feasibility Studies
                      Political Risk Insurance
                      Technical Assistance
                      Work With Us
                            Where We Work
                      Investment Policies
                      Eligibility Checklist
                      Apply
                      Our Impact
                            Approach to Impact
                      Transaction Data
                      Reports
                      Transparency
                            Overview
                      Office of Accountability
                      Office of Inspector General
                      Media
                            Newsroom
                      In the News
                      Speeches & Testimony

                                Search...
                Keywords
Apply  Expanding COVID vaccine manufacturing capacity in Southeast Asia
 AsiaAsiaMore from Asia

    
        HealthcareHealthcareMore from Healthcare

    
        COVID-19 ResponseCOVID-19 ResponseMore from COVID-19 Response

    
        2X Women's Initiative2X Women's InitiativeMore from 2X Women's Initiative

    
        Global Health and Prosperity InitiativeGlobal Health and Prosperity InitiativeMore from Global Health and Prosperity Initiative
            Challenge

The highly contagious Delta variant in India in early 2021 led to a swift surge in COVID cases and deaths throughout Southeast Asia. At the time of the Delta surge in India, less than five percent of India’s population had been vaccinated.

Solution and Impact

DFC financing is helping Indian vaccine manufacturer, Biological E Limited, expand production capacity for at least one billion additional COVID vaccine doses.

After initially focusing on production for distribution in India, Biological E has extended its focus to other developing countries where supply is most limited. The company is also continuing to expand its development and production of vaccines for a variety of infectious and childhood diseases. Additional production capacity supported by DFC financing will enable the company to begin producing a new oral polio vaccine. Biological E supplies vaccines to 100 countries around the world.
 Follow UsStay connected with DFC news and updates!
Sign Up
      
        U.S. International Development Finance Corporation1100 New York Ave NW, Washington, DC 20527Info@dfc.gov | +1 (202) 336-8400
                            
                                                Footer - Quick Links 1
  

        
      White House
                      usa.gov
                      Office of Inspector General
                      Archived Reports
                      Privacy
                      Accessibility
                      Vulnerability Disclosure Form
                      Information Quality Guidelines
                      FOIA
                      EEO Office ×
 Keywords
Apply